Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome

BACKGROUND AND AIMS: Hepatorenal syndrome is a major complication in patients with cirrhosis and associated with high mortality. Predictive biomarkers for therapy response are largely missing. Cytokeratin18‐based cell death markers are significantly elevated in patients with complications of chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinrich, Sophia, Austgen, Thomas, Castven, Darko, Hess, Moritz, Labenz, Christian, Kirstein, Martha, Zimpel, Carolin, Stockhoff, Lena, Maasoumy, Benjamin, Heinrich, Bernd, Wedemeyer, Hans Heinrich, Galle, Peter Robert, Binder, Harald, Nguyen‐Tat, Marc, Marquardt, Jens Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892429/
https://www.ncbi.nlm.nih.gov/pubmed/36441143
http://dx.doi.org/10.1002/ueg2.12337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892429/
https://www.ncbi.nlm.nih.gov/pubmed/36441143
http://dx.doi.org/10.1002/ueg2.12337

Ejemplares similares